New Leaf Fund Investment Strategy Overview

New Leaf Fund Investment Strategy Overview The passage is a generic description of an investment fund's diligence process and portfolio strategy. It contains no specific names, transactions, dates, or allegations linking powerful actors to misconduct, offering no actionable investigative leads. Key insights: Outlines risk factors considered for biotech and tech investments; Describes fund's team-based approach and board placement policy; Targets a portfolio of 24‑28 companies across biopharma, information convergence, and medical devices